Hypertrust Patient Data Care (HPDC) has launched its extended Hypertrust X-Chain supply chain management solution for Advanced & Personalized Therapies (APT). The company states that it is the first solution that allows biotech and pharmaceutical companies to design, set up, plan, orchestrate, operate and scale APT supply chains with one single system.
The new applications added to Hypertrust X-Chain are:
Hypertrust X-Chain can be implemented as an all-in-one supply chain management solution or flexibly with a focus on specific modules to complement existing system landscapes.
HPDC adds that different modules of Hypertrust X-Chain are combinable, configurable, and scalable to manage end-to-end supply chain needs across all therapy life cycle phases, from the clinical phase up to post-commercialization.
Click to enlarge.
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.